Choueiri, T. K., Xie, W., D’Amico, A. V., Ross, R. W., Hu, J. C., Pomerantz, M., . . . Oh, W. K. (2009). Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy.
Dyfyniad Arddull ChicagoChoueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.
Dyfyniad MLAChoueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.